1887

Abstract

Epstein–Barr virus (EBV) HI-A rightward transcripts (BARTs; also designated complementary strand transcripts or CSTs) have been demonstrated to contain several splicing forms in EBV-infected cells. To date, however, little is known about the actual full-length splicing form and its functions. In the present study, we proved that six forms of BARTs were present in EBV-positive cell lines and various tissue specimens with different EBV infection patterns. Of the BART-encoded genes, mRNA of four major splicing forms, including BARF0, RPMS1, RPMS1A and A73, were expressed in all EBV-infected cells. On the other hand, mRNA of two minor splicing forms, RK-BARF0 and RB3, was rarely detected, or if at all, at very low expression levels. Both RPMS1A and RPMS1 mRNA was transcribed at higher levels in EBV-infected cells. In particular, RPMS1 mRNA was expressed abundantly in epithelial carcinoma cells, including gastric carcinoma and nasopharyngeal carcinoma, in association with a lytic infection signal, BZLF1 mRNA. The four major splicing forms were expressed much less in B-cell lines with an integrated EBV genome than in those with episomal EBV genomes. These data indicate that at least six splicing forms can be expressed by EBV-infected cells or tissues, although the expression patterns or levels differ for different infection states such as lytic and latent infections.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.044727-0
2012-10-01
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/10/1445.html?itemId=/content/journal/jmm/10.1099/jmm.0.044727-0&mimeType=html&fmt=ahah

References

  1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C.. & other authors ( 1984;). DNA sequence and expression of the B95-8 Epstein–Barr virus genome. . Nature 310:, 207–211. [CrossRef][PubMed]
    [Google Scholar]
  2. Brooks L. A., Lear A. L., Young L. S., Rickinson A. B.. ( 1993;). Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. . J Virol 67:, 3182–3190.[PubMed]
    [Google Scholar]
  3. Cai X., Schäfer A., Lu S., Bilello J. P., Desrosiers R. C., Edwards R., Raab-Traub N., Cullen B. R.. ( 2006;). Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. . PLoS Pathog 2:, e23. [CrossRef][PubMed]
    [Google Scholar]
  4. Chen H. L., Lung M. M., Sham J. S., Choy D. T., Griffin B. E., Ng M. H.. ( 1992;). Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. . Virology 191:, 193–201. [CrossRef][PubMed]
    [Google Scholar]
  5. Chen H., Smith P., Ambinder R. F., Hayward S. D.. ( 1999;). Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. . Blood 93:, 3026–3032.[PubMed]
    [Google Scholar]
  6. Chen H., Huang J., Wu F. Y., Liao G., Hutt-Fletcher L., Hayward S. D.. ( 2005;). Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. . J Virol 79:, 1724–1733. [CrossRef][PubMed]
    [Google Scholar]
  7. Chevallier-Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A.. ( 1986;). Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. . EMBO J 5:, 3243–3249.[PubMed]
    [Google Scholar]
  8. Chien Y. C., Chen J. Y., Liu M. Y., Yang H. I., Hsu M. M., Chen C. J., Yang C. S.. ( 2001;). Serologic markers of Epstein–Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. . N Engl J Med 345:, 1877–1882. [CrossRef][PubMed]
    [Google Scholar]
  9. Daibata M., Taguchi T., Nemoto Y., Saito T., Machida H., Imai S., Miyoshi I., Taguchi H.. ( 2002;). Epstein–Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL): chromosomal integration of EBV in a novel CD2-positive PAL B-cell line. . Br J Haematol 117:, 546–557. [CrossRef][PubMed]
    [Google Scholar]
  10. de Jesus O., Smith P. R., Spender L. C., Elgueta Karstegl C., Niller H. H., Huang D., Farrell P. J.. ( 2003;). Updated Epstein–Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. . J Gen Virol 84:, 1443–1450. [CrossRef][PubMed]
    [Google Scholar]
  11. Edwards R. H., Marquitz A. R., Raab-Traub N.. ( 2008;). Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. . J Virol 82:, 9094–9106. [CrossRef][PubMed]
    [Google Scholar]
  12. Fries K. L., Sculley T. B., Webster-Cyriaque J., Rajadurai P., Sadler R. H., Raab-Traub N.. ( 1997;). Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. . J Virol 71:, 2765–2771.[PubMed]
    [Google Scholar]
  13. Gilligan K. J., Rajadurai P., Lin J. C., Busson P., Abdel-Hamid M., Prasad U., Tursz T., Raab-Traub N.. ( 1991;). Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. . J Virol 65:, 6252–6259.[PubMed]
    [Google Scholar]
  14. Hitt M. M., Allday M. J., Hara T., Karran L., Jones M. D., Busson P., Tursz T., Ernberg I., Griffin B. E.. ( 1989;). EBV gene expression in an NPC-related tumour. . EMBO J 8:, 2639–2651.[PubMed]
    [Google Scholar]
  15. Hoshikawa Y., Satoh Y., Murakami M., Maeta M., Kaibara N., Ito H., Kurata T., Sairenji T.. ( 2002;). Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. . J Med Virol 66:, 351–359. [CrossRef][PubMed]
    [Google Scholar]
  16. Imai S., Nishikawa J., Takada K.. ( 1998;). Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. . J Virol 72:, 4371–4378.[PubMed]
    [Google Scholar]
  17. Karran L., Gao Y., Smith P. R., Griffin B. E.. ( 1992;). Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. . Proc Natl Acad Sci U S A 89:, 8058–8062. [CrossRef][PubMed]
    [Google Scholar]
  18. Kienzle N., Sculley T. B., Poulsen L., Buck M., Cross S., Raab-Traub N., Khanna R.. ( 1998;). Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. . J Virol 72:, 6614–6620.[PubMed]
    [Google Scholar]
  19. Kienzle N., Sculley T. B., Greco S., Khanna R.. ( 1999;). Cutting edge: silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: a novel implication of RNA processing for antigen presentation. . J Immunol 162:, 6963–6966.[PubMed]
    [Google Scholar]
  20. Lawrence J. B., Villnave C. A., Singer R. H.. ( 1988;). Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. . Cell 52:, 51–61. [CrossRef][PubMed]
    [Google Scholar]
  21. Lear A. L., Rowe M., Kurilla M. G., Lee S., Henderson S., Kieff E., Rickinson A. B.. ( 1992;). The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. . J Virol 66:, 7461–7468.[PubMed]
    [Google Scholar]
  22. Ooka T., De Turenne M., De The G., Daillie J.. ( 1984;). Epstein-Barr virus-specific DNase activity in nonproducer Raji cells after treatment with 12-o-tetradecanoylphorbol-13-acetate and sodium butyrate. . J Virol 49:, 626–628.[PubMed]
    [Google Scholar]
  23. Parker B. D., Bankier A., Satchwell S., Barrell B., Farrell P. J.. ( 1990;). Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. . Virology 179:, 339–346. [CrossRef][PubMed]
    [Google Scholar]
  24. Pfeffer S., Zavolan M., Grässer F. A., Chien M., Russo J. J., Ju J., John B., Enright A. J., Marks D.. & other authors ( 2004;). Identification of virus-encoded microRNAs. . Science 304:, 734–736. [CrossRef][PubMed]
    [Google Scholar]
  25. Rickinson A. B., Kieff E.. ( 2001;). Epstein-Barr Virus. . In Fields Virology, pp. 2575–2627. Philadelphia, PA:: Lippincott-Raven;.
    [Google Scholar]
  26. Sadler R. H., Raab-Traub N.. ( 1995;). Structural analyses of the Epstein-Barr virus BamHI A transcripts. . J Virol 69:, 1132–1141.[PubMed]
    [Google Scholar]
  27. Smith P. R.. ( 2001;). Epstein–Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. . Semin Cancer Biol 11:, 469–476. [CrossRef][PubMed]
    [Google Scholar]
  28. Smith P. R., Gao Y., Karran L., Jones M. D., Snudden D., Griffin B. E.. ( 1993;). Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. . J Virol 67:, 3217–3225.[PubMed]
    [Google Scholar]
  29. Smith P. R., de Jesus O., Turner D., Hollyoake M., Karstegl C. E., Griffin B. E., Karran L., Wang Y., Hayward S. D., Farrell P. J.. ( 2000;). Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. . J Virol 74:, 3082–3092. [CrossRef][PubMed]
    [Google Scholar]
  30. Speck S. H., Chatila T., Flemington E.. ( 1997;). Reactivation of Epstein–Barr virus: regulation and function of the BZLF1 gene. . Trends Microbiol 5:, 399–405. [CrossRef][PubMed]
    [Google Scholar]
  31. Takakuwa T., Luo W. J., Ham M. F., Mizuki M., Iuchi K., Aozasa K.. ( 2003;). Establishment and characterization of unique cell lines derived from pyothorax-associated lymphoma which develops in long-standing pyothorax and is strongly associated with Epstein-Barr virus infection. . Cancer Sci 94:, 858–863. [CrossRef][PubMed]
    [Google Scholar]
  32. Yamamoto T., Tsuji K., Suzuki D., Morizane S., Iwatsuki K.. ( 2007;). A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts. . J Microbiol Methods 68:, 403–407. [CrossRef][PubMed]
    [Google Scholar]
  33. Zhang C. X., Ooka T.. ( 1995;). Expression of the complementary-strand transcripts from BamHI-A region of the Epstein-Barr virus genome in various induced virus-carrying B cell lines. . Virology 208:, 180–188. [CrossRef][PubMed]
    [Google Scholar]
  34. Zhang J., Chen H., Weinmaster G., Hayward S. D.. ( 2001;). Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. . J Virol 75:, 2946–2956. [CrossRef][PubMed]
    [Google Scholar]
  35. zur Hausen H., O’Neill F. J., Freese U. K., Hecker E.. ( 1978;). Persisting oncogenic herpesvirus induced by the tumour promotor TPA. . Nature 272:, 373–375. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.044727-0
Loading
/content/journal/jmm/10.1099/jmm.0.044727-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error